134 related articles for article (PubMed ID: 32722819)
1. Quality of Life and Treatment Satisfaction in Participants with Maturity-Onset Diabetes of the Young: A Comparison to Other Major Forms of Diabetes.
Dusatkova P; Pavlikova M; Spirkova A; Elblova L; Zdarska DJ; Rozenkova K; Hron J; Sumnik Z; Cinek O; Lebl J; Pruhova S
Exp Clin Endocrinol Diabetes; 2022 Feb; 130(2):85-93. PubMed ID: 32722819
[TBL] [Abstract][Full Text] [Related]
2. Quality of life assessment in patients with HNF1A-MODY and GCK-MODY.
Szopa M; Matejko B; Ucieklak D; Uchman A; Hohendorff J; Mrozińska S; Głodzik W; Zapała B; Płatek T; Solecka I; Sani CM; Małecki MT
Endocrine; 2019 May; 64(2):246-253. PubMed ID: 30421137
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, clinical features and complications of common forms of Maturity Onset Diabetes of the Young (MODY) seen at a tertiary diabetes centre in south India.
Aarthy R; Aston-Mourney K; Amutha A; Mikocka-Walus A; Anjana RM; Unnikrishnan R; Jebarani S; Venkatesan U; Gopi S; Radha V; Mohan V
Prim Care Diabetes; 2023 Aug; 17(4):401-407. PubMed ID: 37055265
[TBL] [Abstract][Full Text] [Related]
4. Beta cell function and insulin sensitivity in obese youth with maturity onset diabetes of youth mutations vs type 2 diabetes in TODAY: Longitudinal observations and glycemic failure.
Arslanian S; El Ghormli L; Haymond MH; Chan CL; Chernausek SD; Gandica RG; Gubitosi-Klug R; Levitsky LL; Siska M; Willi SM;
Pediatr Diabetes; 2020 Jun; 21(4):575-585. PubMed ID: 32064729
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels.
Ping F; Fu J; Xiao X
Front Endocrinol (Lausanne); 2022; 13():1024431. PubMed ID: 36387841
[TBL] [Abstract][Full Text] [Related]
6. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin.
Shepherd MH; Shields BM; Hudson M; Pearson ER; Hyde C; Ellard S; Hattersley AT; Patel KA;
Diabetologia; 2018 Dec; 61(12):2520-2527. PubMed ID: 30229274
[TBL] [Abstract][Full Text] [Related]
7. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.
Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L;
Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900
[TBL] [Abstract][Full Text] [Related]
8. Maturity-Onset Diabetes of the Young (MODY) in Portugal: Novel
Alvelos MI; Gonçalves CI; Coutinho E; Almeida JT; Bastos M; Sampaio ML; Melo M; Martins S; Dinis I; Mirante A; Gomes L; Saraiva J; Pereira BD; Gama-de-Sousa S; Moreno C; Guelho D; Martins D; Baptista C; Barros L; Ventura M; Gomes MM; Lemos MC
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31968686
[TBL] [Abstract][Full Text] [Related]
9. A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
Hohendorff J; Szopa M; Skupien J; Kapusta M; Zapala B; Platek T; Mrozinska S; Parpan T; Glodzik W; Ludwig-Galezowska A; Kiec-Wilk B; Klupa T; Malecki MT
Endocrine; 2017 Aug; 57(2):272-279. PubMed ID: 28593615
[TBL] [Abstract][Full Text] [Related]
10. Genetic basis of early-onset, maturity-onset diabetes of the young-like diabetes in Japan and features of patients without mutations in the major MODY genes: Dominance of maternal inheritance.
Yorifuji T; Higuchi S; Kawakita R; Hosokawa Y; Aoyama T; Murakami A; Kawae Y; Hatake K; Nagasaka H; Tamagawa N
Pediatr Diabetes; 2018 Nov; 19(7):1164-1172. PubMed ID: 29927023
[TBL] [Abstract][Full Text] [Related]
11. The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young.
Bacon S; Schmid J; McCarthy A; Edwards J; Fleming A; Kinsley B; Firth R; Byrne B; Gavin C; Byrne MM
Am J Obstet Gynecol; 2015 Aug; 213(2):236.e1-7. PubMed ID: 25935773
[TBL] [Abstract][Full Text] [Related]
12. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
[TBL] [Abstract][Full Text] [Related]
13. Effects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.
Kyithar MP; Bonner C; Bacon S; Kilbride SM; Schmid J; Graf R; Prehn JH; Byrne MM
J Transl Med; 2013 Jun; 11():156. PubMed ID: 23803251
[TBL] [Abstract][Full Text] [Related]
14. Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database.
Warncke K; Kummer S; Raile K; Grulich-Henn J; Woelfle J; Steichen E; Prinz N; Holl RW
J Clin Endocrinol Metab; 2019 Mar; 104(3):845-855. PubMed ID: 30535056
[TBL] [Abstract][Full Text] [Related]
15. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
[TBL] [Abstract][Full Text] [Related]
16. The Mutation Spectrum of Maturity Onset Diabetes of the Young (MODY)-Associated Genes among Western Siberia Patients.
Ivanoshchuk DE; Shakhtshneider EV; Rymar OD; Ovsyannikova AK; Mikhailova SV; Fishman VS; Valeev ES; Orlov PS; Voevoda MI
J Pers Med; 2021 Jan; 11(1):. PubMed ID: 33477506
[TBL] [Abstract][Full Text] [Related]
17. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families.
Costa A; Bescós M; Velho G; Chêvre J; Vidal J; Sesmilo G; Bellanné-Chantelot C; Froguel P; Casamitjana R; Rivera-Fillat F; Gomis R; Conget I
Eur J Endocrinol; 2000 Apr; 142(4):380-6. PubMed ID: 10754480
[TBL] [Abstract][Full Text] [Related]
18. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J
Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393
[TBL] [Abstract][Full Text] [Related]
19. Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young.
Ellard S; Thomas K; Edghill EL; Owens M; Ambye L; Cropper J; Little J; Strachan M; Stride A; Ersoy B; Eiberg H; Pedersen O; Shepherd MH; Hansen T; Harries LW; Hattersley AT
Diabetologia; 2007 Nov; 50(11):2313-7. PubMed ID: 17828387
[TBL] [Abstract][Full Text] [Related]
20. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes.
Ming-Qiang Z; Yang-Li D; Ke H; Wei W; Jun-Fen F; Chao-Chun Z; Guan-Ping D
J Pediatr Endocrinol Metab; 2019 Jul; 32(7):759-765. PubMed ID: 31216263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
